168 related articles for article (PubMed ID: 32122956)
1. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
[TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
3. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
[TBL] [Abstract][Full Text] [Related]
4. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
[TBL] [Abstract][Full Text] [Related]
5. Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer.
Wang C; Liu Q; Huang M; Zhou Q; Zhang X; Zhang J; Xie R; Yu Y; Chen S; Fan J; Chen X
FASEB J; 2020 Apr; 34(4):5754-5766. PubMed ID: 32103545
[TBL] [Abstract][Full Text] [Related]
6. TCF21 regulates miR-10a-5p/LIN28B signaling to block the proliferation and invasion of melanoma cells.
Zhu H; Kang M; Bai X
PLoS One; 2021; 16(8):e0255971. PubMed ID: 34424910
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
8. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
10. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
11. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance and biological role of TCF21 mRNA in breast cancer.
Wang J; Gao X; Wang M; Zhang J
Tumour Biol; 2015 Nov; 36(11):8679-83. PubMed ID: 26044559
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer.
Wei J; Zhang L; Li J; Zhu S; Tai M; Mason CW; Chapman JA; Reynolds EA; Weiner CP; Zhou HH
J Ovarian Res; 2017 May; 10(1):33. PubMed ID: 28476165
[TBL] [Abstract][Full Text] [Related]
15. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
[TBL] [Abstract][Full Text] [Related]
16. miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer.
Zhang L; Xu J; Yang G; Li H; Guo X
Oncol Res; 2018 Jul; 26(6):949-957. PubMed ID: 29298735
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
18. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.
Yang Z; Li DM; Xie Q; Dai DQ
J Cancer Res Clin Oncol; 2015 Feb; 141(2):211-20. PubMed ID: 25156819
[TBL] [Abstract][Full Text] [Related]
19. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR-25-3p to inhibit the co-expression of TCF21 and HHIP.
Ouyang Y; Tang Y; Fu L; Peng S; Wu W; Tan D; Fu X
Cell Prolif; 2020 Jul; 53(7):e12833. PubMed ID: 32525231
[TBL] [Abstract][Full Text] [Related]
20. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway.
Su Y; Feng W; Shi J; Chen L; Huang J; Lin T
Mol Cancer; 2020 Feb; 19(1):23. PubMed ID: 32019579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
